The prevalence of irritable bowel syndrome and chronic idiopathic constipation rose significantly during the COVID-19 pandemic.

In patients with IBD on maintenance IFX, use of 5-ASA and immunomodulators does not significantly reduce flares, infections, or adverse reactions.

Self-help cognitive behavioral therapy for irritable bowel syndrome was successfully delivered via mobile application.

Patients with gastroesophageal reflux disease are at increased risk of developing lung cancer, according to a study presented at DDW 2025.

In biologic-naive patients with CD, there were no differences in clinical remission or disease progression between those who ...

Liver disease was associated with reduced protection against influenza-associated hospitalization following influenza vaccination.

The FDA has granted Orphan Drug designation to TPST-1495, dual receptor inhibitor of prostaglandin signaling, for the treatment of familial adenomatous polyposis.

Early-life mutagenic exposure to colibactin-producing bacteria may be associated with increased incidence of early-onset colorectal cancer.

White patients had an increased burden of advanced liver fibrosis vs Black patients, despite comparable levels of inflammation.

Among patients hospitalized with HRS-AKI who were not waitlisted for a liver transplant, terlipressin led to HRS reversal.

Data-driven clustering reveals distinct obesity phenotypes with unique clinical, behavioral, microbiome features, and ...

Pfizer has made the decision to discontinue the clinical development program for danuglipron, an oral GLP-1 receptor agonist, being investigated for chronic weight management.